de Siqueira R J B, Ribeiro-Filho H V, Freire R S, Cosker F, Freire W B S, Vasconcelos-Silva A A, Soares M A, Lahlou S, Magalhães P J C
Department of Physiology and Pharmacology, School of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil.
Department of Physiology and Pharmacology, School of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil.
Vascul Pharmacol. 2014 Oct;63(1):37-45. doi: 10.1016/j.vph.2014.06.006. Epub 2014 Aug 14.
Previous findings enable us to hypothesize that (-)-α-bisabolol acts as inhibitor of voltage-dependent Ca(2+) channels in smooth muscle. The current study was aimed at consolidating such hypothesis through the recording of isometric tension, measurement of intracellular Ca(2+) as well as discovery of channel target using in silico analysis. In rat aortic rings, (-)-α-bisabolol (1-1000 µM) relaxed KCl- and phenylephrine-elicited contractions, but the IC50 differed significantly (22.8 [17.6-27.7] and 200.7 [120.4-334.6] µM, respectively). The relaxation of phenylephrine contractions remained unaffected by l-NAME, indomethacin, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, tetraethylammonium, glibenclamide or KT-5720. Under Ca(2+)-free conditions, (-)-α-bisabolol did not alter the contractions evoked by phenylephrine or caffeine whereas it reduced those evoked by CaCl2 in KCl-, but not in PHE-stimulated preparations. Furthermore, it did not significantly alter the contractions evoked by phorbol 12,13-dibutyrate or induced by the extracellular Ca(2+) restoration in cyclopiazonic acid-treated preparations. In mesenteric rings loaded with Fluo-4 AM, (-)-α-bisabolol blunted the tension and the cytosolic levels of Ca(2+) in response to K(+) but not to norepinephrine. Silico docking analysis of the Cavβ2a subunit of voltage-dependent Ca(2+) channel indicated putative docking sites for (-)-α-bisabolol. These findings reinforce the ability of (-)-α-bisabolol to inhibit preferentially contractile responses evoked by Ca(2+) influx through voltage-dependent Ca(2+) channels.
先前的研究结果使我们能够假设,(-)-α-红没药醇可作为平滑肌中电压依赖性Ca(2+)通道的抑制剂。本研究旨在通过记录等长张力、测量细胞内Ca(2+)以及使用计算机分析发现通道靶点来巩固这一假设。在大鼠主动脉环中,(-)-α-红没药醇(1-1000 µM)可松弛氯化钾和去氧肾上腺素引起的收缩,但半数抑制浓度(IC50)差异显著(分别为22.8 [17.6-27.7]和200.7 [120.4-334.6] µM)。去氧肾上腺素收缩的松弛不受左旋精氨酸甲酯(l-NAME)、吲哚美辛、1H-[1,2,4]恶二唑并[4,3-a]喹喔啉-1-酮、四乙铵、格列本脲或KT-5720的影响。在无Ca(2+)条件下,(-)-α-红没药醇不会改变去氧肾上腺素或咖啡因引起的收缩,而在氯化钾刺激而非去氧肾上腺素刺激的制剂中,它会降低氯化钙引起的收缩。此外,它不会显著改变佛波醇12,13-二丁酸酯引起的收缩或环匹阿尼酸处理制剂中细胞外Ca(2+)恢复诱导的收缩。在加载Fluo-4 AM的肠系膜环中,(-)-α-红没药醇可减弱对钾离子(K+)而非去甲肾上腺素的张力和细胞溶质Ca(2+)水平。电压依赖性Ca(2+)通道Cavβ2a亚基的计算机对接分析表明存在(-)-α-红没药醇的假定对接位点。这些发现强化了(-)-α-红没药醇优先抑制通过电压依赖性Ca(2+)通道的Ca(2+)内流引起的收缩反应的能力。